Stephen Brand

The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR

Stephen Brand, Ryûji Kobayashi, Michael B. Mathews · Journal of Biological Chemistry · 1997 · 148 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

Stephen Brand, Thorsten P. Degenhardt, Karen Person et al. · American Journal of Obstetrics and Gynecology · 2018 · 78 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections

Mark G. Martens, Bassem Maximos, Thorsten P. Degenhardt et al. · American Journal of Obstetrics and Gynecology · 2022 · 77 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent <i>In Vitro</i> Activity against Cryptococcus neoformans and Cryptococcus gattii

Shawn R. Lockhart, Annette W. Fothergill, Naureen Iqbal et al. · Antimicrobial Agents and Chemotherapy · 2016 · 66 citations · Full text

Medicine, Microbiology, Pharmacology +15

Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection

Wei Ge, Jacqueline Arp, Dameng Lian et al. · Transplantation · 2010 · 63 citations

Life Sciences, Immunology, Pharmacotherapy +17